Read by Will Collyer, Charles Graeber

Follow along as this New York Times bestselling author details the astonishing scientific discovery of the code to unleashing the human immune system to fight in this "captivating and heartbreaking" book (The Wall Street Journal). For decades, scientists have puzzled over one of medicine's most confounding mysteries: Why doesn't our immune system recognize and fight cancer the way it does other diseases, like the common cold? As it turns out, the answer to that question can be traced to a series of tricks that cancer has developed to turn off normal immune responses -- tricks that scientists have only recently discovered and learned to defeat. The result is what many are calling cancer's "penicillin moment," a revolutionary discovery in our understanding of cancer and how to beat it. In The Breakthrough, New York Times bestselling author of The Good Nurse Charles Graeber guides readers through the revolutionary scientific research bringing immunotherapy out of the realm of the miraculous and into the forefront of twenty-first-century medical science. As advances in the fields of cancer research and the human immune system continue to fuel a therapeutic arms race among biotech and pharmaceutical research centers around the world, the next step -- harnessing the wealth of new information to create modern and more effective patient therapies -- is unfolding at an unprecedented pace, rapidly redefining our relationship with this all-too-human disease. Groundbreaking, riveting, and expertly told, The Breakthrough is the story of the game-changing scientific discoveries that unleash our natural ability to recognize and defeat cancer, as told through the experiences of the patients, physicians, and cancer immunotherapy researchers who are on the front lines. This is the incredible true story of the race to find a cure, a dispatch from the life-changing world of modern oncological science, and a brave new chapter in medical history. Charles Graeber is the Edgar Award-nominated, New York Timesbestselling author of The Good Nurse. Winner of the Overseas Press Club award for outstanding international journalism, he has contributed to numerous publications, including Wired, GQ, the New Yorker, New York Magazine, Bloomberg Businessweek, and the New York Times. His work has been included in The Best American Science Writing, The Best American Crime Writing, and other anthologies. Born in Iowa, he's now based out of Brooklyn, NY. "The Breakthrough not only provides good background and good understanding for patients, but is also a wonderful read, a book easily picked up but not easily put down -- I'd recommend it for any patient interested in immunology of cancer."-Dr. James L. Gulley M.D. Ph.D., Director of Medical Oncology, Cheif of Immunology, National Cancer Institute (NCI), National Institutes of Health (NIH) "THE BREAKTHROUGH artfully traces the history of old and new developments that may have -- finally -- resulted in an actual cure for the most dreaded of all diseases. This book and the advances it describes offer far more than the usual glimmer of does a good job of hacking through it all, interspersing the medical research with interesting accounts of patients and their determined physicians."-The New York Times "A gripping chronicle of the 100-year overnight success of Immunotherapy. For myself and millions of other cancer survivors, THE BREAKTHROUGH is a book of immense and essential hope."-Michael Fitzgerald, co-founder and CEO of Submittable and author of Radiant Days "Only Graeber, one of America's greatest non-fiction writers, could take a subject so complex, dense and sprawling and turn it into a rollicking high-tension medical thriller. Masterful."-Douglas Rogers, award-winning journalist and author of The Last Resort "There is no villain more ruthless than cancer, which has robbed us all of loved ones who had to endure untold suffering before they succumbed. But after decades of frustration

Mode of access: World Wide Web